Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies.Continue

Emerade adrenaline auto-injector

Certain risk materials on this website are intended for use by healthcare professionals only.

By proceeding you are confirming that you are a healthcare professional.

You can leave feedback on specific Risk Minimisation Materials or make general observations about how they are displayed on the eMC by leaving comments in the box below.

Please note that we are unable to respond to medical queries.

Emerade adrenaline auto-injector


Please enter your email address below

Tick here if you wish to recieve a response to your feedback

Risk Materials
VIEW

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Emerade Expiry Reminder

Expiry Reminder for Emerade, 150 micrograms; 300 micrograms; 500 micrograms, solution for injection in pre-filled pen.

How to use Emerade instruction video

Demonstration video for Emerade, 150 micrograms; 300 micrograms; 500 micrograms, solution for injection in pre-filled pen.

CLOSE THIS PANEL
View Patient Information Leaflet

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine.

This PIL is in PDF format and so you must have a PDF reader installed on your device to read it.

Company Information

Bausch & Lomb U.K Limited

Address : Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK

Telephone : +44 (0)208 781 2900

Fax : +44 (0)208 781 2901

Medical Information Direct Line : +44(0)1748 828849 or 08 1871 9318

Medical Information e-mail :

Customer Care direct line : +44 (0)208781 2991

More information about this medicine
© 2017 Datapharm Communications Ltd